InvestorsHub Logo
Followers 52
Posts 5322
Boards Moderated 0
Alias Born 09/16/2013

Re: Virgilio post# 211297

Thursday, 01/31/2019 3:53:39 PM

Thursday, January 31, 2019 3:53:39 PM

Post# of 700924
This is a 7-year p3 trial on the most deadliest cancer and is close to completion. It has run at over 80 sites in multiple continent and has multi-country manufacturing practically in place, neurosurgeons and many hospitals and cancer centers have already been trained on its use. It has reported blended/blinded data with a tail that is unheard of...significantly better than NOVOCORE's OPTUNE device and no toxicity in comparison to the car-t drugs.

NWBO should be valued much, much more...imho.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News